The full blood count as a biomarker of outcome and toxicity in ipilimumab‐treated cutaneous metastatic melanoma

Ipilimumab produces durable responses in some metastatic melanoma patients. Neutrophil, platelet, and eosinophil to lymphocyte ratios (NLR, PLR, and ELR) may be associated with the immune response in cancer thereby acting as biomarkers of toxicity and efficacy in ipilimumab‐treated patients. Data we...

Descripción completa

Detalles Bibliográficos
Autores principales: Khoja, Leila, Atenafu, Eshetu G., Templeton, Arnoud, Qye, Ye, Chappell, Mary Anne, Saibil, Sam, Hogg, David, Butler, Marcus O., Joshua, Anthony M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5083732/
https://www.ncbi.nlm.nih.gov/pubmed/27683208
http://dx.doi.org/10.1002/cam4.878

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5083732/
https://www.ncbi.nlm.nih.gov/pubmed/27683208
http://dx.doi.org/10.1002/cam4.878

Ejemplares similares